Pyrrole compounds and uses thereof
View Patent ↗The invention provides pyrrole-containing compounds and methods of use thereof. Kits and pharmaceutical compositions comprising the pyrrole compounds of the invention are also provided. The compounds and compositions disclosed herein are preferably used in the treatment of neurodegenerative diseases, cardiovascular diseases, proliferative diseases, and visual disorders. In particular, methods and compositions for the treatment of stroke are disclosed herein.
1. A pyrrole compound having the formula:
or a diastereomer, enantiomer, or pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable excipient.
3. A method of treating stroke comprising administering to a subject in need thereof an effective amount of a compound of claim 1 .
4. The method of claim 3 , wherein the method is for treating post stroke trauma.
5. A method for treating trauma associated with stroke comprising administering to a subject in need thereof an effective amount of a compound of claim 1 after said stroke.
6. The method of claim 5 , wherein said compound is administered within the first 48 hours of the onset of symptoms.
7. The method of claim 5 , wherein said compound is administered within the first 6 hours of the onset of symptoms.
8. The method of claim 5 , wherein said compound is administered within the first 3 hours of the onset of symptoms.
9. The method of claim 5 , wherein said compound is administered via intravenous injection, bolus injection, a pill, a capsule, transdermal patch or buccal delivery.
10. A kit comprising a carrier, package or container, wherein said carrier, package or container(s) comprises a compound of formula:
or a diastereomer, enantiomer, or pharmaceutically acceptable salt thereof, and wherein said kit optionally comprises one or more additional containers, each said container comprising one or more reagents or materials.
11. The kit of claim 10 , wherein said containers are selected from bottles, vials, syringes and test tubes.
12. The kit of claim 10 , wherein said materials are selected from buffers, diluents, filters, needles, syringes, carrier, package, container, vial and instructions for use.
13. The compound of claim 1 , wherein the compound is
14. The compound of claim 1 , wherein the compound is a diastereomer of the compound of formula
15. The compound of claim 1 , wherein the compound is an enantiomer of the compound of formula
16. The compound of claim 1 , wherein the compound is a pharmaceutically acceptable salt of the compound of formula